HB 1102

  • Illinois House Bill
  • 104th Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Ins Cd-Cancer Screenings

Abstract

Amends the Illinois Insurance Code. In a provision concerning coverage of certain cancer screenings, adds having a high level of CA-125, as indicated by a blood test screening, to the definition of "at risk for ovarian cancer". Provides that "surveillance tests for ovarian cancer" means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings (instead of an annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination). Effective January 1, 2027.

Bill Sponsors (1)

Votes


No votes to display

Actions


Mar 21, 2025

House

House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

House

Rule 19(a) / Re-referred to Rules Committee

Mar 19, 2025

House

House Committee Amendment No. 1 Rules Refers to Insurance Committee

Mar 18, 2025

House

House Committee Amendment No. 1 Filed with Clerk by Rep. Jed Davis

House

House Committee Amendment No. 1 Referred to Rules Committee

Mar 12, 2025

House

To Insurance Main Subcommittee

Feb 04, 2025

House

Assigned to Insurance Committee

Jan 09, 2025

House

First Reading

House

Referred to Rules Committee

Jan 03, 2025

House

Prefiled with Clerk by Rep. Jed Davis

Bill Text

Bill Text Versions Format
Introduced HTML PDF
House Amendment 001 HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.